- Home
- GDTC vs CCM Comparison
GDTC vs CCM Comparison
Compare GDTC & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- CCM
- Stock Information
- Founded
- GDTC 2018
- CCM 1997
- Country
- GDTC Singapore
- CCM China
- Employees
- GDTC N/A
- CCM N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- CCM Medical/Nursing Services
- Sector
- GDTC Health Care
- CCM Health Care
- Exchange
- GDTC Nasdaq
- CCM Nasdaq
- Market Cap
- GDTC 24.8M
- CCM 23.8M
- IPO Year
- GDTC 2023
- CCM 2009
- Fundamental
- Price
- GDTC $1.95
- CCM $4.82
- Analyst Decision
- GDTC
- CCM
- Analyst Count
- GDTC 0
- CCM 0
- Target Price
- GDTC N/A
- CCM N/A
- AVG Volume (30 Days)
- GDTC 268.9K
- CCM 42.1K
- Earning Date
- GDTC 01-01-0001
- CCM 09-26-2025
- Dividend Yield
- GDTC N/A
- CCM N/A
- EPS Growth
- GDTC N/A
- CCM N/A
- EPS
- GDTC N/A
- CCM N/A
- Revenue
- GDTC $573,193.00
- CCM $51,056,841.00
- Revenue This Year
- GDTC $5.37
- CCM N/A
- Revenue Next Year
- GDTC N/A
- CCM N/A
- P/E Ratio
- GDTC N/A
- CCM N/A
- Revenue Growth
- GDTC 63.03
- CCM N/A
- 52 Week Low
- GDTC $1.65
- CCM $3.80
- 52 Week High
- GDTC $4.05
- CCM $10.77
- Technical
- Relative Strength Index (RSI)
- GDTC 42.90
- CCM 38.25
- Support Level
- GDTC $1.68
- CCM $5.18
- Resistance Level
- GDTC $3.10
- CCM $5.77
- Average True Range (ATR)
- GDTC 0.34
- CCM 0.46
- MACD
- GDTC -0.06
- CCM -0.03
- Stochastic Oscillator
- GDTC 14.96
- CCM 8.66
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.